My Account

Risk Management
Workers Comp & Safety
Employee Benefits
International
People
Events
BI Intelligence
Magazine
- Current Issue
- Past Issues
DEI Institute

Recent Quotes

View Full List

My Watchlist

Indicators

Business Insurance Index

Markets:

Overview

News

Currencies

International

Treasuries

Merck & Co (NY:MRK)

92.92 -0.01 (-0.01%)

Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Merck & Co

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

5 Top Stocks to Buy for March ↗

March 08, 2025

These 5 stocks look rather intriguing at current levels.

Via The Motley Fool

In a market where value is scarce, MERCK & CO. INC. (NYSE:MRK) offers a refreshing opportunity with its solid fundamentals. ↗

March 08, 2025

Discover MERCK & CO. INC., an undervalued stock. NYSE:MRK showcases solid financial health and profitability while maintaining an appealing valuation.

Via Chartmill

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Merck & Co.

March 08, 2025

From Faruqi & Faruqi LLP

Via GlobeNewswire

ImmunityBio Analyst Predicts Strong 2025 For New Bladder Cancer Drug ↗

March 06, 2025

HC Wainwright initiates coverage on ImmunityBio with a Buy rating, citing Anktiva's growth potential. The firm projects $4.3 billion in sales, up from $137M in 2025.

Via Benzinga

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against FMC, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm

March 04, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

Spotlight on Merck & Co: Analyzing the Surge in Options Activity ↗

March 04, 2025

Via Benzinga

ROSEN, A LEADING NATIONAL FIRM, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

March 04, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Branded Pharmaceuticals Stocks Q4 In Review: Bristol-Myers Squibb (NYSE:BMY) Vs Peers

March 04, 2025

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Bristol-Myers Squibb (NYSE:BMY) and the best...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Pfizer CEO Says Company May Shift Overseas Manufacturing To US Amid Looming Tariff Threats: 'Will The Trump Administration Co-Invest', Asks Analyst ↗

March 04, 2025

In light of potential tariff threats from President Donald Trump, Pfizer Inc.'s (PFE.N) CEO Albert Bourla has suggested the possibility of shifting the company's overseas manufacturing to its U.S....

Via Benzinga

Topics Government World Trade

These S&P 500 Stocks Have Low P/E Ratios — Time to Buy?

March 03, 2025

This article covers three stocks included in the S&P 500 which are showing exceptionally low P/E ratios of 20 or less, indicating potential buys.

Via MarketBeat

Topics Stocks

Decoding Merck & Co's Options Activity: What's the Big Picture? ↗

February 27, 2025

Via Benzinga

Is Merck Stock a Buy? ↗

February 22, 2025

Via The Motley Fool

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

March 03, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

These Vanguard ETFs Show Where the Smart Money Is Moving Now ↗

March 03, 2025

Via The Motley Fool

Topics ETFs

Deadline Alert: Merck & Co (MRK) Investors Who Lost Money Urged to Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit

February 28, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

4 Sectors That Thrive When Inflation Runs Hot

February 28, 2025

Sticky inflation and higher-for-longer interest rates is causing a rotation out of technology stocks, here are four sectors for investors hunting for value

Via MarketBeat

Topics Economy World Trade

Deadline Approaching: Merck & Co (MRK) Investors Who Lost Money Urged To Contact Law Offices of Howard G. Smith

February 27, 2025

From Law Offices of Howard G. Smith

Via Business Wire

NovoCure Q4 EPS Misses, Revenue Matches ↗

February 27, 2025

NovoCure reported a solid jump in revenue, but earnings fell short due to rising costs and adoption challenges.

Via The Motley Fool

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Merck & Co., Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MRK

February 26, 2025

From The Rosen Law Firm PA

Via GlobeNewswire

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Edison, Elastic, Intellia, and Merck and Encourages Investors to Contact the Firm

February 25, 2025

From Bragar Eagel & Squire

Via GlobeNewswire

MRK INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Merck & Co., Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

February 25, 2025

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Law Offices of Frank R. Cruz Encourages Merck & Co (MRK) Investors to Inquire About Securities Fraud Class Action

February 25, 2025

From Law Offices of Frank R. Cruz

Via Business Wire

MERCK & CO., INC. (NYSE: MRK) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Merck & Co., Inc. Investors of Upcoming Deadline

February 25, 2025

From Bernstein Liebhard LLP

Via GlobeNewswire

FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Standard of Care as Perioperative Treatment for Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma

February 25, 2025

From Merck & Co., Inc.

Via Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm Encourages Merck & Co (MRK) Investors To Inquire About Securities Fraud Class Action

February 24, 2025

From Glancy Prongay & Murray LLP

Via Business Wire

3 Magnificent S&P 500 Dividend Stocks Down 36% to 64% to Buy and Hold Forever ↗

February 24, 2025

The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.

Via The Motley Fool

Topics Stocks

Merck to Participate in the TD Cowen 45th Annual Health Care Conference

February 24, 2025

From Merck & Co., Inc.

Via Business Wire

Wall Street Thinks This Weight-Loss Drug Stock Could More Than 3X Over the Next 12 Months -- and It's Not Eli Lilly or Novo Nordisk ↗

February 24, 2025

Via The Motley Fool

Trump Reportedly Warns Big Pharma: Move Manufacturing To US Or Face Tariffs ↗

February 24, 2025

President Donald Trump has issued a stringent warning to pharmaceutical companies, advising them to repatriate their manufacturing to the US or face the possibility of tariffs.

Via Benzinga

Topics Government

Law Offices of Howard G. Smith Encourages Merck & Co (MRK) Investors To Inquire About Securities Fraud Class Action

February 21, 2025

From Law Offices of Howard G. Smith

Via Business Wire

< Previous 1 2

...

17 18 19 20 21 22 23 24 25

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.

Information

About Us
Contact
Advertise
Privacy Policy
Terms & Condition